Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management, with some now specifically licensed for weight management in the UK
There is also a long-standing pattern of womens symptoms being minimized or attributed to stress, anxiety, or burnout
A Morgan Stanley survey found a twofold increase in weekly exercise for individuals after beginning their weight-loss drug regimen
Because traditional management strategies necessitate that the patient must be self-reliant for glucose monitoring and insulin delivery, periods when he or she cannot be as vigilant, such as while sleeping, can present problems
Using proteomic approaches, SIR has been identified as a TRX target in wheat seeds (Wong et al., 2004) and in Synechocystis (Lindahl and Florencio, 2003)
It's crucial to trust the process and listen to your healthcare team